Jim Simons Aslan Pharmaceuticals LTD Transaction History

Renaissance Technologies LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.36 - $24.24 $37,185 - $2.5 Million	-103,292 Reduced 28.24%	262,508 $95,000
Q3 2022 Nov 14, 2022	SELL	$0.42 - $24.68 $46,240 - $2.72 Million	-110,096 Reduced 23.13%	365,800 $219,000
Q2 2022 Aug 12, 2022	BUY	$0.36 - $0.9 $145,906 - $364,766	405,296 Added 574.07%	475,896 $236,000
Q1 2022 May 13, 2022	BUY	$0.74 - $1.22 $52,244 - $86,132	70,600 New	70,600 $64,000
Q4 2021 Feb 11, 2022	SELL	$1.11 - $1.86 $131,599 - $220,517	-118,558 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$1.78 - $3.41 $429,141 - $822,120	-241,091 Reduced 67.04%	118,558 $211,000
Q2 2021 Aug 13, 2021	BUY	$2.5 - $3.72 $252,955 - $376,397	101,182 Added 39.15%	359,649 $1.19 Million
Q1 2021 May 13, 2021	SELL	$1.86 - $5.25 $123,598 - $348,867	-66,451 Reduced 20.45%	258,467 $866,000
Q4 2020 Feb 10, 2021	BUY	$1.54 - $2.22 $380,407 - $548,379	247,018 Added 317.1%	324,918 $595,000
Q3 2020 Nov 13, 2020	SELL	$1.41 - $2.04 $70,711 - $102,306	-50,150 Reduced 39.16%	77,900 $148,000
Q2 2020 Aug 13, 2020	BUY	$0.96 - $2.19 $50,771 - $115,822	52,887 Added 70.36%	128,050 $256,000
Q1 2020 May 14, 2020	BUY	$0.93 - $2.8 $53,719 - $161,736	57,763 Added 331.97%	75,163 $77,000
Q4 2019 Feb 13, 2020	BUY	$0.37 - $5.2 $6,438 - $90,480	17,400 New	17,400 $35,000

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $41.8M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.